tiprankstipranks
Trending News
More News >
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS

Apellis Pharmaceuticals (APLS) Revenue

Compare
895 Followers

Apellis Pharmaceuticals Revenue

Apellis Pharmaceuticals had a revenue of 212.53M in the quarter ending Dec 31, 2024, with 7.98%. This bring the company's revenue in the last twelve months to 781.37M, Decreased 9.25%. In the fiscal year ending Dec 31, 2024, Apellis Pharmaceuticals had annual revenue of 781.37M with 97.02% growth.
Revenue (ttm)
781.37M
Revenue Growth
48.04%
P/S Ratio
3.10
Revenue/Employee
$1,108,322
Employees
705
Market Cap
$2.42B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
781.37M384.78M+97.02%
Dec 31, 2023
396.59M321.17M+425.83%
Dec 31, 2022
75.42M8.86M+13.31%
Dec 31, 2021
66.56M-184.08M-73.44%
Dec 31, 2020
250.65M+∞%
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis